Important Alert: Neurotoxic Medication List Update | Charcot-Marie-Tooth Association

Important Alert: Neurotoxic Medication List Update

ALERT! ALERT! ALERT!

Medications added to moderate-to-significant-risk category

Dr. Louis Weimer of Columbia University recently updated the CMTA’s neurotoxic medication list as part of his review for an upcoming issue of Current Neurology and Neuroscience Reports.

CMT Medical AlertThere are a number of additions to the moderate-to-high risk category:

  • Arsenic Trioxide (Trisenox)
Immune Checkpoint Inhibitors
  • Ipilimumab (Yervoy)
  • Nivolumab (Opdivo)
  • Pembrolizumab (Keytruda)
Immunomodulatory Drugs (IMiDs)
  • Lenalidomide (Revlimid)
  • Pomalidomide (Pomalyst)
Monoclonal Antibodies
  • Cetuximab (Erbitux)
  • Brentuximab Vedotin (Adcetris)

To view the complete list of neurotoxic medications, visit:

Complete Neurotoxic Medication List